RVNC
Charles Schwab’s Revance Therapeutics, Inc. RVNC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-797,299
| Closed | -$2.42M | – | 3535 |
|
|
2024
Q4 | $2.42M | Buy |
797,299
+6,462
| +0.8% | +$19.6K | ﹤0.01% | 2617 |
|
|
2024
Q3 | $4.1M | Buy |
790,837
+41,250
| +6% | +$214K | ﹤0.01% | 2466 |
|
|
2024
Q2 | $1.93M | Buy |
749,587
+49,537
| +7% | +$127K | ﹤0.01% | 2712 |
|
|
2024
Q1 | $3.44M | Buy |
700,050
+22,686
| +3% | +$112K | ﹤0.01% | 2424 |
|
|
2023
Q4 | $5.95M | Buy |
677,364
+13,826
| +2% | +$122K | ﹤0.01% | 2230 |
|
|
2023
Q3 | $7.61M | Buy |
663,538
+36,493
| +6% | +$419K | ﹤0.01% | 2059 |
|
|
2023
Q2 | $15.9M | Buy |
627,045
+19,710
| +3% | +$499K | ﹤0.01% | 1653 |
|
|
2023
Q1 | $19.6M | Buy |
607,335
+717
| +0.1% | +$23.1K | 0.01% | 1492 |
|
|
2022
Q4 | $11.2M | Buy |
606,618
+38,059
| +7% | +$703K | ﹤0.01% | 1801 |
|
|
2022
Q3 | $15.4M | Buy |
568,559
+86,844
| +18% | +$2.34M | 0.01% | 1569 |
|
|
2022
Q2 | $6.66M | Sell |
481,715
-9,747
| -2% | -$135K | ﹤0.01% | 2051 |
|
|
2022
Q1 | $9.58M | Buy |
491,462
+14,638
| +3% | +$285K | ﹤0.01% | 1981 |
|
|
2021
Q4 | $7.78M | Buy |
476,824
+5,557
| +1% | +$90.7K | ﹤0.01% | 2132 |
|
|
2021
Q3 | $13.1M | Buy |
471,267
+3,056
| +0.7% | +$85.1K | ﹤0.01% | 1851 |
|
|
2021
Q2 | $13.9M | Buy |
468,211
+21,270
| +5% | +$630K | ﹤0.01% | 1820 |
|
|
2021
Q1 | $12.5M | Buy |
446,941
+35,910
| +9% | +$1M | ﹤0.01% | 1827 |
|
|
2020
Q4 | $11.6M | Buy |
411,031
+5,169
| +1% | +$146K | ﹤0.01% | 1773 |
|
|
2020
Q3 | $10.2M | Buy |
405,862
+69,842
| +21% | +$1.76M | ﹤0.01% | 1681 |
|
|
2020
Q2 | $8.21M | Buy |
336,020
+30,846
| +10% | +$753K | ﹤0.01% | 1764 |
|
|
2020
Q1 | $4.52M | Buy |
305,174
+35,815
| +13% | +$530K | ﹤0.01% | 1885 |
|
|
2019
Q4 | $4.37M | Buy |
269,359
+24,274
| +10% | +$394K | ﹤0.01% | 2088 |
|
|
2019
Q3 | $3.19M | Buy |
245,085
+2,321
| +1% | +$30.2K | ﹤0.01% | 2196 |
|
|
2019
Q2 | $3.15M | Buy |
242,764
+17,383
| +8% | +$225K | ﹤0.01% | 2183 |
|
|
2019
Q1 | $3.55M | Buy |
225,381
+48,353
| +27% | +$762K | ﹤0.01% | 2140 |
|
|
2018
Q4 | $3.56M | Sell |
177,028
-898
| -0.5% | -$18.1K | ﹤0.01% | 2080 |
|
|
2018
Q3 | $4.42M | Buy |
177,926
+25,131
| +16% | +$625K | ﹤0.01% | 2109 |
|
|
2018
Q2 | $4.2M | Buy |
152,795
+18,179
| +14% | +$499K | ﹤0.01% | 2089 |
|
|
2018
Q1 | $4.15M | Buy |
134,616
+16,307
| +14% | +$502K | ﹤0.01% | 2038 |
|
|
2017
Q4 | $4.23M | Buy |
118,309
+1,051
| +0.9% | +$37.6K | ﹤0.01% | 2008 |
|
|
2017
Q3 | $3.23M | Buy |
117,258
+5,501
| +5% | +$152K | ﹤0.01% | 2090 |
|
|
2017
Q2 | $2.95M | Buy |
111,757
+19,267
| +21% | +$509K | ﹤0.01% | 2082 |
|
|
2017
Q1 | $1.92M | Buy |
92,490
+3,933
| +4% | +$81.8K | ﹤0.01% | 2213 |
|
|
2016
Q4 | $1.83M | Buy |
88,557
+28,842
| +48% | +$597K | ﹤0.01% | 2213 |
|
|
2016
Q3 | $968K | Sell |
59,715
-6,548
| -10% | -$106K | ﹤0.01% | 2418 |
|
|
2016
Q2 | $902K | Buy |
66,263
+1,320
| +2% | +$18K | ﹤0.01% | 2385 |
|
|
2016
Q1 | $1.13M | Buy |
64,943
+1,476
| +2% | +$25.8K | ﹤0.01% | 2290 |
|
|
2015
Q4 | $2.17M | Buy |
63,467
+16,625
| +35% | +$568K | ﹤0.01% | 2032 |
|
|
2015
Q3 | $1.4M | Buy |
46,842
+10,608
| +29% | +$316K | ﹤0.01% | 2249 |
|
|
2015
Q2 | $1.16M | Buy |
36,234
+9,561
| +36% | +$306K | ﹤0.01% | 2356 |
|
|
2015
Q1 | $553K | Buy |
26,673
+1,508
| +6% | +$31.3K | ﹤0.01% | 2595 |
|
|
2014
Q4 | $427K | Buy |
25,165
+5,918
| +31% | +$100K | ﹤0.01% | 2683 |
|
|
2014
Q3 | $373K | Buy |
19,247
+3,819
| +25% | +$74K | ﹤0.01% | 2697 |
|
|
2014
Q2 | $525K | Buy |
+15,428
| New | +$525K | ﹤0.01% | 2605 |
|